Compounded Peptide
PE-22-28
Active Ingredient:
N/A
- Promotes Neurogenesis: Encourages the creation of new nerve cells
- Enhances Synaptogenesis: Aids in the formation of new neural connections
- Mood Regulation: Inhibits TREK-1, a channel protein linked to mood
- Reduced Side Effects: Fewer adverse effects compared to existing antidepressants
- Improves Memory: Supports memory enhancement and cognitive function
In simple terms, PE-22-28 is a promising candidate for developing a new wave of antidepressants and enhancing brain function as a nootropic. It also plays a role in expanding therapeutic options for neurodegenerative conditions like Alzheimer’s disease.
The main benefits include enhanced neurogenesis, improved mood regulation, and reduced side effects compared to traditional antidepressants. It also shows promise in the treatment of neurodegenerative diseases.
The administration method of PE-22-28 can vary, and modifications have been made to enhance its half-life or change its delivery method. It is typically administered under medical supervision.
Individuals with a history of hypersensitivity to peptides or those currently pregnant or breastfeeding should avoid using PE-22-28. Always consult with a healthcare provider before starting any new medication.
PE-22-28 is primarily used for treating depression and may also have therapeutic potential for neurodegenerative conditions like Alzheimer’s disease.
How it works
1. SIGN UP
Schedule a free online consultation with our healthcare consultants.
2. Get Prescribed
Hassle free online consultation with Philippine licensed doctors. Get our innovative treatments customized for you.
3. Delivery
Your customized medication will be sent to your doorstep.
